₹0.31
■ +0 +0.00%
17 Jul 2026
BSE Listed
Supha Pharmachem Limited (539561)
Volume: 5,36,032Avg Vol 1W: 15,31,641Avg Vol 1M: 39,68,73352W Range:₹0.25₹1.8
Key Ratios
Checked just nowMarket Cap₹27 Cr
Current Price₹0.31
Previous Close₹0.31
High / Low (52w)₹1.8 / ₹0.25
Volume5,36,032
Avg Vol (1W)15,31,641
Avg Vol (1M)39,68,733
Stock P/E15.5
Book Value₹1.04
Dividend Yield0%
ROE0%
ROA69.12%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding88 Cr
Face Value—
EPS (TTM)₹0.02
P/B0.3
Debt / Equity26.01
50 DMA₹0.35
200 DMA₹0.87
Day change+0.00%
Price Chart
₹0.31▼ 74.17% · 1Y
2025-07-172026-07-17
20-day avg volume: 29.2L shares
Pros
- Company is almost debt-free.
- Stock trades below its book value.
Quarterly Results
| Metric | Mar 2025 | Jun 2025 | Sept 2025 |
|---|---|---|---|
| Revenue | ₹264 Cr | ₹113 Cr | ₹111 Cr |
| EBITDA | ₹0 Cr | ₹5 Cr | ₹11 Cr |
| Net Profit | ₹-2 Cr | ₹5 Cr | ₹9 Cr |
| EPS | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 |
|---|---|
| Revenue | ₹416 Cr |
| EBITDA | ₹10 Cr |
| Net Profit | ₹2 Cr |
| EPS | 0.05 |
Balance Sheet
| Metric | Mar 2025 |
|---|---|
| Total Assets | ₹1,720 Cr |
| Total Liabilities | ₹1,676 Cr |
| Equity | ₹44 Cr |
| Total Debt | — |
Cash Flow
| Metric | Mar 2025 |
|---|---|
| Operating | ₹-1,135 Cr |
| Investing | ₹0 Cr |
| Financing | ₹1,136 Cr |
| Free Cash Flow | ₹-1,135 Cr |
Shareholding
Promoter 1.13% Institutions 1.7% Public 97.17%
Efficiency & Working Capital
ROCE0%
Interest Coverage1.6
Dividend Payout—
Debtor Days695 d
Inventory Days243 d
Payable Days451 d
Cash Conversion Cycle486 d
Working Capital Days938 d
Shareholding Details
As of 2025-12-31
Promoter1.1%
FII1.7%
DII0%
Institutions1.7%
Public97.2%
Promoter Pledge0%
No. of Shareholders1,11,269
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jul 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Jul 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 1.1% | 1.1% | 1.1% | 1.1% | 1.1% | 1.1% | 1.1% | 1.1% | 1.1% | 1.1% | 1.1% | 1.1% |
| FIIs | 0% | 0.1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1.7% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 98.8% | 98.8% | 98.8% | 98.8% | 98.9% | 98.9% | 98.9% | 98.9% | 98.9% | 98.9% | 98.9% | 97.2% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 2,065 | 3,988 | 3,859 | 15,587 | 26,464 | 41,565 | 67,404 | 73,637 | 1,10,422 | 1,13,543 | 1,14,119 | 1,11,269 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Uppinangady Sudhindra Nayak | Public Shareholding | 3.2% | 2.82 Cr |
| Manju Devi | Public Shareholding | 2.5% | 2.17 Cr |
| L7 Hitech Private Limited | Public Shareholding | 2.3% | 2.07 Cr |
| Kamal Asnani | Public Shareholding | 2.2% | 1.93 Cr |
| Zeta Global Funds (oeic) Pcc Limited-zeta Series B Fund Pc | Public Shareholding | 1.7% | 1.50 Cr |
| Comfort Capital Private Limited | Public Shareholding | 1.7% | 1.46 Cr |
| Randeep Singh | Public Shareholding | 1.2% | 1.08 Cr |
| Siddharth Chimanlal Shah | Shareholding of Promoter and Promoter Group | 1.1% | 99,45,600 |
| Krishna Kumar Goyal | Public Shareholding | 1.1% | 94,86,069 |
| Vignesh Prabhu Hejamadi | Public Shareholding | 1.1% | 93,65,285 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Siddharth Chimanlal Shah | 0 | 0% | 2025-12-31 |
| Zeta Global Funds (oeic) Pcc Limited-zeta Series B Fund Pc | 0 | 0% | 2025-12-31 |
| Manju Devi | 0 | 0% | 2025-12-31 |
| Uppinangady Sudhindra Nayak | 0 | 0% | 2025-12-31 |
| Kamal Asnani | 0 | 0% | 2025-12-31 |
| Randeep Singh | 0 | 0% | 2025-12-31 |
| Vignesh Prabhu Hejamadi | 0 | 0% | 2025-12-31 |
| Krishna Kumar Goyal | 0 | 0% | 2025-12-31 |
| L7 Hitech Private Limited | 0 | 0% | 2025-12-31 |
| Comfort Capital Private Limited | 0 | 0% | 2025-12-31 |
| Siddharth Chimanlal Shah | 0 | 0% | 2025-09-30 |
| Kamal Asnani | 0 | 0% | 2025-09-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Adarsh Deepak Munjal | Whole-time Director | 2025 |
| Dipesh Vaidya | Independent Non Exe. Director | 2025 |
| Shamim Adil Michal | Independent Non Exe. Director | 2025 |
| Bikram Kumar Mund | Independent Non Exe. Director | 2025 |
| VIJAY PAL SINGH GULYA | Independent Non Exe. Director | 2025 |
| Kapil Goplani | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹1 | 110 | 40 | 40 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
Company Information
🌐 www.remlife.com ↗
📍 Office No 601 Hyder Park, Saki Vihar Road Andheri East, Mumbai, Maharashtra, 400072
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Apoorva Leasing Finance &Agribio Spirits LimitedNarayana HrudayalayaF Mec International FinanDeep Health AI India LimitedMalt Land Distilleries LimitedShivansh Finserv LimitedMishtann Foods LimitedDelta Industrial ResourceCredent Global Finance LimitedAmpl Capital LimitedKotia Enterprises LimitedAll “53” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search